IRIS
COSTANZO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.902
AS - Asia 8.093
EU - Europa 2.165
SA - Sud America 1.641
AF - Africa 352
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 19
AN - Antartide 1
Totale 24.201
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.649
SG - Singapore 5.131
BR - Brasile 1.365
CN - Cina 1.241
VN - Vietnam 804
FI - Finlandia 376
IE - Irlanda 330
IT - Italia 261
DE - Germania 243
NG - Nigeria 225
HK - Hong Kong 205
FR - Francia 192
GB - Regno Unito 183
IN - India 165
CA - Canada 138
NL - Olanda 124
AR - Argentina 108
BD - Bangladesh 87
TR - Turchia 71
MX - Messico 67
SE - Svezia 67
RU - Federazione Russa 57
BE - Belgio 53
EC - Ecuador 50
ES - Italia 50
IQ - Iraq 49
ID - Indonesia 44
UA - Ucraina 42
ZA - Sudafrica 42
PK - Pakistan 40
PL - Polonia 38
JP - Giappone 32
IL - Israele 28
CL - Cile 24
VE - Venezuela 22
CO - Colombia 21
AU - Australia 20
JO - Giordania 19
PE - Perù 18
UZ - Uzbekistan 18
CZ - Repubblica Ceca 17
SA - Arabia Saudita 17
PY - Paraguay 16
RO - Romania 16
GR - Grecia 15
PH - Filippine 15
EG - Egitto 14
TN - Tunisia 14
DO - Repubblica Dominicana 12
A2 - ???statistics.table.value.countryCode.A2??? 11
AZ - Azerbaigian 11
KR - Corea 11
MA - Marocco 11
AE - Emirati Arabi Uniti 10
DZ - Algeria 10
HU - Ungheria 10
LT - Lituania 10
MY - Malesia 10
OM - Oman 10
CH - Svizzera 9
JM - Giamaica 9
KE - Kenya 9
AL - Albania 8
AT - Austria 8
ET - Etiopia 8
NP - Nepal 8
RS - Serbia 8
TH - Thailandia 8
UY - Uruguay 8
KZ - Kazakistan 7
NZ - Nuova Zelanda 7
DK - Danimarca 6
IR - Iran 6
KG - Kirghizistan 6
PA - Panama 6
PS - Palestinian Territory 6
PT - Portogallo 6
BG - Bulgaria 5
MD - Moldavia 5
NI - Nicaragua 5
NO - Norvegia 5
SN - Senegal 5
XK - ???statistics.table.value.countryCode.XK??? 5
AO - Angola 4
BO - Bolivia 4
CR - Costa Rica 4
LB - Libano 4
LV - Lettonia 4
LY - Libia 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BN - Brunei Darussalam 3
EU - Europa 3
KH - Cambogia 3
KW - Kuwait 3
QA - Qatar 3
SR - Suriname 3
TT - Trinidad e Tobago 3
Totale 24.161
Salva come PNG Salva come JPEG
Città #
Singapore 2.200
Chandler 1.695
Wilmington 1.446
Ashburn 1.013
The Dalles 730
Shanghai 671
San Mateo 575
San Jose 510
Dallas 468
Ann Arbor 453
Helsinki 373
Boardman 356
Dublin 329
Ho Chi Minh City 294
Lawrence 261
Princeton 261
Leawood 259
Beijing 244
New York 227
Benin City 223
Hong Kong 187
Hanoi 180
Fairfield 146
Paris 138
Woodbridge 131
São Paulo 125
Amsterdam 99
Los Angeles 97
London 75
Milan 72
Seattle 67
Santa Clara 63
Toronto 57
Brussels 50
Phoenix 48
Orem 44
San Diego 42
Council Bluffs 41
Belo Horizonte 40
Rio de Janeiro 37
Chennai 35
Falls Church 33
Haiphong 32
Da Nang 30
Brooklyn 29
Tokyo 29
Kocaeli 28
Falkenstein 27
Warsaw 27
Johannesburg 26
Manchester 26
Montreal 25
Norwalk 25
Chicago 24
Houston 24
San Francisco 23
Columbus 19
Frankfurt am Main 19
Munich 19
Guarulhos 18
Amman 17
Hải Dương 17
Tashkent 17
Campinas 16
Goiânia 16
Quito 16
Redmond 16
Curitiba 15
Moscow 15
Salvador 15
Baghdad 14
Can Tho 14
Charlotte 14
Lima 14
New Delhi 14
Atlanta 13
Boston 13
Dhaka 13
Guayaquil 13
Istanbul 13
Lahore 13
Sorocaba 13
Stockholm 13
Assago 12
Buenos Aires 12
Fortaleza 12
Mexico City 12
Poplar 12
Porto Alegre 12
Biên Hòa 11
Brasília 11
Brno 11
Jakarta 11
Pune 11
Rome 11
Mumbai 10
Ninh Bình 10
Baku 9
Buffalo 9
Cairo 9
Totale 15.364
Salva come PNG Salva come JPEG
Nome #
Living with Chronic Spontaneous Urticaria in Italy: A Narrative Medicine Project to Improve the Pathway of Patient Care 327
Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study 264
Melanoma in Adolescents and Young Adults (AYAs): An Italian Multi-Centric Retrospective Experience 201
CD28 costimulation regulates FOXP3 in a RelA/NF-κB-dependent mechanism. 138
y Clinical similarity of the biosimilar ABP 501 compared with adalimumab after single transition: long-term results from a randomized controlled, double-blind, 52-week, phase III trial in patients with moderate-to-severe plaque psoriasis 126
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naive patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial 114
Adalimumab for severe psoriasis and psoriatic arthritis: An open-label study in 30 patients previously treated with other biologics 113
IL-21 in the pathogenesis and treatment of skin diseases. 110
Rosacea-like Acute Reaction After Hyaluronic Acid Dermal Filler 110
Chronic Hand Eczema (CHE): A Narrative Review 109
Actinic keratosis treated with an immune response modifier: a case report of six patients 109
Brodalumab: a new way to inhibit IL-17 in psoriasis 108
'Living with chronic urticaria': a study through narrative medicine to improve the quality of care 108
How to make a skin-tight dress: the p63/claudin-1 connection 105
A role of p73 in mitotic exit 105
A p38-dependent pathway regulates DNp63 DNA binding to p53 dependent promoters in UV-induced apoptosis of keratinocytes 102
Herpes simplex virus disrupts NF-kappa B regulation by blocking its recruitment on the I kappa B alpha promoter and directing the factor on viral genes 102
Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway 102
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias 101
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 101
A feedback regulatory loop between p63 and Dlx3: implications for epidermal differentiation 100
A symphony of regulations centered on p63 to control development of ectoderm-derived structures. 100
Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes. 100
Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis 99
FGF8, c-Abl and p300 participate in a pathway that controls stability and function of the Delta Np63 alpha protein 99
A role for the p63-IKKalpha pathway in the development of ectodermal dysplasias 98
Psoriasis: from pathogenesis to novel therapeutic approaches. 96
A p38-dependent pathway regulates Delta Np63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytes 96
Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients 96
DNA Methylation Signature in Monozygotic Twins Discordant for Psoriatic Disease 95
A fatal case of COVID-19 infection presenting with an erythema multiforme-like eruption and fever 94
Adalimumab for severe psoriasis and psoriatic arthritis: an open label study in 30 patients previously treated with other biologics 93
Adalimumab for the treatment of severe psoriasis and psoriatic arthritis 92
p63-dependent and independent mechanisms of nectin-1 and -4 regulation in the epidermis. 92
A myogenic differentiation checkpoint activated by genotoxic stress 92
Efalizumab 90
Specific Infiltrate of Hodgkin Lymphoma at Site of Cellulitis Mimicking Secondary Cutaneous Involvement 90
Programmed cell death in the skin 89
Zosteriform metastasis of occult bronchogenic carcinoma. 89
Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris. 88
p63 induces key target genes required for epidermal morphogenesis 87
The p53/p63/p73 family of transcription factors: overlapping and distinct functions. . 2000 May;113 ( Pt 10):1661-70 86
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappa B subunits on IL-8 and Bcl-xL gene promotors 86
Noninferiority of biosimilar MSB110222 to reference adalimumab for chronic plaque psoriasis 86
p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis 86
Ustekinumab for treatment of plaque psoriasis in a patient with Down syndrome. 86
No metagenomic evidence of tumorigenic viruses in cancers from a selected cohort of immunosuppressed subjects 86
Topical use of valproic acid for the prevention or treatment of skin disorders 86
Role of the HLA-C(star)06 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patients 85
Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants epsilon and zeta 85
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19 85
Two new p73 splice variants, gamma and delta, with different transcriptional activity 84
IKKalpha downregulation in psoriasis: New insights in the pathway regulating keratinocyte proliferation 84
High-dose intravenous immunoglobulin for severe drug reactions: Efficacy in toxic epidermal necrolysis 84
Infliximab in psoriasis and psoriatic arthritis. 84
Anti-IL17 and anti-IL23 biologic drugs for scalp psoriasis: A single-center retrospective comparative study 84
Treatment of psoriasis and psoriatic arthritis. 83
TRIM8 and p53: making the right decision. 83
Living Matter Observations with a Novel Hyperspectral Supercontinuum Confocal Microscope for VIS to Near-IR Reflectance Spectroscopy 83
Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling 83
HLACw6 predisposes to clinical response to IL12/23 blocker ustekinumab: Results of short- and long-term treatment in anti-TNF naive patients 83
Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope 83
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 83
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 83
Diagnosis and management of moderate to severe adult atopic dermatitis: a Consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA) 82
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target. 81
The p73 gene is an anti-tumoral target of the RAR beta/gamma-selective retinoid tazarotene 81
c-E10 is a caspase-recruiting domain-containing protein that interacts with components of death receptors signaling pathway and activates nuclear factor-kappaB 81
Role of p63 in keratinocyte differentiation and proliferation 81
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis 81
Patients with moderate to severe plaque psoriasis: one year after the European Medicines Agency recommendation of efalizumab suspension. 81
Prevalence and genomic variability of transfusion transmitted virus in Italian cryptogenic chronic liver disease and healthy blood donors. 81
Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis. Gastroenterology. 1997 Oct;113(4):1384-9 81
Keratosis punctata palmoplantaris and malignancies: Case report 80
Patient-relevant needs and treatment goals in nail psoriasis. 80
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody. 79
Delta Np63 knockdown mice: a mouse model for AEC syndrome 79
Ashy dermatosis: clinico-pathological associations in two cases] 79
Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab 79
Vav cooperates with CD28 to induce NF-kappa B activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1 79
Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single- center real-life population 79
Apremilast for the treatment of palmo-plantar non-pustular psoriasis: A real-life single-center retrospective study 79
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy 78
HLA‐C*06 and psoriasis: susceptibility, phenotype, course and response to treatment 78
DNp73 alpha protects myogenic cells from apoptosis. 77
Safety and efficacy study on etanercept in patients with plaque psoriasis 77
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response 77
Elementi di dermatologia 77
Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients 77
Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study 76
Psychiatric comorbidity and suicidal ideation in psoriasis, melanoma and allergic disorders 76
European consensus statement on phenotypes of pustular psoriasis 76
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study 76
Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX. 75
Biomarkers to optimize ustekinumab therapy in psoriatic patients 75
Nuclear factor kB-independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2 75
Histone deacetylases as new therapeutical targets for the treatment of Non-Melanoma Skin Cancer: results of phase I/IIa trial with topical DAC060 75
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 74
Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study 74
p73 is regulated by phosphorylation at the G2/M transition 74
Totale 9.381
Salva come PNG Salva come JPEG
Categoria #
all - tutte 159.521
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.521
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021635 0 0 0 0 0 0 0 0 0 358 3 274
2021/20221.472 49 12 19 323 21 38 57 195 143 111 413 91
2022/20234.235 595 166 374 543 399 390 5 353 790 319 242 59
2023/20242.627 158 237 592 68 54 222 174 416 44 54 211 397
2024/20254.124 107 80 45 64 66 427 260 396 571 981 533 594
2025/20269.336 1.598 688 662 999 392 426 3.116 519 549 387 0 0
Totale 24.469